Skip to the page

Data / Form D filings / Ribonaut Therapeutics, Inc.

Ribonaut Therapeutics, Inc.: Form D filing

Ribonaut Therapeutics, Inc., a biotechnology company in Jupiter, FL, filed a Form D with the SEC in 2023. The latest, on January 4, 2023, reports $6.9 million sold of a $26 million offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
492 PEACOCK LN N, Jupiter, FL, 33458
Phone
(716) 380-7737
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1956680

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 4, 2023New notice$25,999,994$6,917,854$19,082,1406Nov 14, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Zachary CollinsExecutive Officer
Steven TregayDirector
Matthew DisneyExecutive Officer, Director
Lusong LuoDirector
Jessica Childs-DisneyPromoter

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Jan 2, 2023 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Ribonaut Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.